Overview

A Study to Evaluate the Effect of Povorcitinib on the QT/QTc Interval in Healthy Participants

Status:
COMPLETED
Trial end date:
2024-09-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of povorcitinib on the QT/QTc Interval in healthy participants.
Phase:
PHASE1
Details
Lead Sponsor:
Incyte Corporation
Treatments:
Moxifloxacin